Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolina P Zingano

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Cardiac Failure|July 4, 2026
Time to benefit of incretin-based therapies in adiposity-related heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysisBernardo F Spiazzi, Carolina P Zingano, Amanda R Vest
European Journal of Preventive Cardiology|June 5, 2026
Advancing Hypertension Treatment in Obstructive Sleep ApneaBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
Current Hypertension Reports|January 21, 2026
Addressing Hypertension Treatment Disparities Via Renal DenervationBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
The Canadian Journal of Cardiology|May 2, 2026
Venous thromboembolism risk among different statins: a retrospective cohort studyBernardo F Spiazzi, Carolina P Zingano, Akiva Rosenzveig, et al.
American Journal of Preventive Cardiology|July 6, 2026
The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysisCarolina P Zingano, Danielle Brennan, LeAnne Bloedon, et al.
JAMA Cardiology|May 27, 2026
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical TrialBernardo F Spiazzi, Danielle Brennan, Carolina P Zingano, et al.
European Journal of Preventive Cardiology|April 11, 2026
Effect of bempedoic acid in the absence of background lipid-lowering therapy on LDL cholesterol, hsCRP, and cardiovascular outcomes, among statin-intolerant patients: a post-hoc analysis of the CLEAR Outcomes trialCarolina P Zingano, Danielle M Brennan, LeAnne Bloedon, et al.
Diabetes, Obesity & Metabolism|February 23, 2024
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysisLeonardo A Mesquita, Bernardo F Spiazzi, Giovana F Piccoli, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Cardiac Failure|July 4, 2026
Time to benefit of incretin-based therapies in adiposity-related heart failure with mildly reduced or preserved ejection fraction: a systematic review and meta-analysisBernardo F Spiazzi, Carolina P Zingano, Amanda R Vest
European Journal of Preventive Cardiology|June 5, 2026
Advancing Hypertension Treatment in Obstructive Sleep ApneaBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
Current Hypertension Reports|January 21, 2026
Addressing Hypertension Treatment Disparities Via Renal DenervationBernardo F Spiazzi, Carolina P Zingano, Luke J Laffin
The Canadian Journal of Cardiology|May 2, 2026
Venous thromboembolism risk among different statins: a retrospective cohort studyBernardo F Spiazzi, Carolina P Zingano, Akiva Rosenzveig, et al.
American Journal of Preventive Cardiology|July 6, 2026
The impact of bempedoic acid on cardiovascular events across the spectrum of kidney function, a CLEAR Outcomes trial secondary analysisCarolina P Zingano, Danielle Brennan, LeAnne Bloedon, et al.
JAMA Cardiology|May 27, 2026
Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical TrialBernardo F Spiazzi, Danielle Brennan, Carolina P Zingano, et al.
European Journal of Preventive Cardiology|April 11, 2026
Effect of bempedoic acid in the absence of background lipid-lowering therapy on LDL cholesterol, hsCRP, and cardiovascular outcomes, among statin-intolerant patients: a post-hoc analysis of the CLEAR Outcomes trialCarolina P Zingano, Danielle M Brennan, LeAnne Bloedon, et al.
Diabetes, Obesity & Metabolism|February 23, 2024
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysisLeonardo A Mesquita, Bernardo F Spiazzi, Giovana F Piccoli, et al.
Pageof 1